A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation
- PMID: 12441946
- DOI: 10.1016/S0022-5347(05)64174-2
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation
Abstract
Purpose: We compared the efficacy of paroxetine alone and combined with sildenafil in patients complaining of premature ejaculation.
Materials and methods: Enrolled in this study were 80 consecutive potent men 19 to 47 years old (mean age 34) with premature ejaculation but without any obvious organic cause. Pretreatment evaluation included a history, self-administration of the International Index of Erectile Function (IIEF) questionnaire, physical examination and the Meares-Stamey test to exclude genital tract infection. The initial 40 patients received 10 mg. paroxetine daily for 21 days and then 20 mg. as needed, that is 3 to 4 hours before planned sexual activity, for 6 months (group 1). The other group of 40 men received 10 mg. paroxetine daily for 21 days and then 20 mg. as needed plus 50 mg. sildenafil as needed, that is 1 hour before planned sexual activity, for 6 months (group 2). Patients were followed 3 and 6 months after beginning therapy and were evaluated using several general assessment questions, IIEF and ejaculatory latency time.
Results: Mean ejaculatory latency time +/- SE in group 1 was 0.33 +/- 0.04, 3.7 +/- 0.10 (p <0.01) and 4.2 +/- 0.03 (p <0.01) minutes at baseline, 3 and 6-month followup, while in group 2 it was 0.35 +/- 0.03, 4.5 +/- 0.07 (p <0.01) and 5.3 +/- 0.02 (p <0.001) minutes, respectively. When improvement in ejaculatory latency time was compared in the 2 groups, group 2 results proved to be significantly greater (p <0.05). Baseline, and 3 and 6-month mean intercourse satisfaction domain values of the IIEF were 9, 11 and 11 (p = 0.09, not significant), and 9, 11 and 14 (p <0.05) in groups 1 and 2, respectively. Group 2 patients reported significantly greater intercourse satisfaction than those in group 1 (p <0.05). At baseline, 3 and 6 months there was a mean of 0.9 +/- 0.1, 1.7 +/- 0.3 (not significant) and 2.5 +/- 0.3 (p <0.01) coitus episodes weekly in group 1, and 1 +/- 0.2, 2.3 +/- 0.3 (p <0.01) and 3.2 +/- 0.1 (p <0.001) in group 2, respectively. Group 2 patients reported a significantly higher number of coitus episodes weekly (p <0.05). Side effects in the 40 group 1 cases included anejaculation in 1 (2.5%), gastrointestinal upset and/or nausea in 5 (12.5%), headache in 4 (10%) and decreased libido in 2 (5%). Side effects in the 40 group 2 cases included anejaculation in 1 (2.5%), headache in 8 (20%), gastrointestinal upset and/or nausea in 6 (15%) and flushing in 6 (15%). Group 2 patients reported significantly more headaches (p <0.01) and flushing episodes (p <0.001) than those in group 1. After 6 months of treatment 33 men (82.5%) in group 1 and 36 (90%) in group 2 were willing to continue therapy (not significant).
Conclusions: Paroxetine combined with sildenafil appears to provide significantly better results in terms of ejaculatory latency time and intercourse satisfaction versus paroxetine alone in potent patients with premature ejaculation. However, combined treatment is associated with a mild increase in drug related side effects.
Similar articles
-
Psychosocial interventions for premature ejaculation.Cochrane Database Syst Rev. 2011 Aug 10;(8):CD008195. doi: 10.1002/14651858.CD008195.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833964 Review.
-
Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation.Urol Int. 2007;79(1):28-32. doi: 10.1159/000102909. Urol Int. 2007. PMID: 17627164 Clinical Trial.
-
Selective serotonin reuptake inhibitors in the treatment of premature ejaculation.Chin Med J (Engl). 2007 Jun 5;120(11):1000-6. Chin Med J (Engl). 2007. PMID: 17624269 Review.
-
[Comparison between sildenafil plus sertraline and sertraline alone in the treatment of premature ejaculation].Zhonghua Nan Ke Xue. 2005 Jul;11(7):520-2, 525. Zhonghua Nan Ke Xue. 2005. PMID: 16078671 Clinical Trial. Chinese.
-
Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation.Urology. 2003 Jan;61(1):197-200. doi: 10.1016/s0090-4295(02)02075-7. Urology. 2003. PMID: 12559295
Cited by
-
Combined on-demand sildenafil citrate and tramadol hydrochloride is an effective and safe treatment for premature ejaculation: A randomized placebo-controlled double-blind clinical trial.Arab J Urol. 2023 Nov 30;22(2):89-95. doi: 10.1080/20905998.2023.2287869. eCollection 2024. Arab J Urol. 2023. PMID: 38481408 Free PMC article.
-
Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives.Pharmaceuticals (Basel). 2023 Sep 6;16(9):1266. doi: 10.3390/ph16091266. Pharmaceuticals (Basel). 2023. PMID: 37765073 Free PMC article. Review.
-
Traditional, Complementary and Alternative Medicines in the Treatment of Ejaculatory Disorders: A Systematic Review.Medicina (Kaunas). 2023 Sep 6;59(9):1607. doi: 10.3390/medicina59091607. Medicina (Kaunas). 2023. PMID: 37763726 Free PMC article. Review.
-
Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation.Arab J Urol. 2022 Jan 23;20(1):49-53. doi: 10.1080/2090598X.2021.2024695. eCollection 2022. Arab J Urol. 2022. PMID: 35223110 Free PMC article.
-
An update on the treatment of premature ejaculation: A systematic review.Arab J Urol. 2021 Aug 4;19(3):281-302. doi: 10.1080/2090598X.2021.1943273. eCollection 2021. Arab J Urol. 2021. PMID: 34552780 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical